1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Eosinophilic Asthma: new trials by email Literature Review of Eosinophilic Asthma trials Research Report on Eosinophilic Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma AD17002, Placebo - Eosinophilic Asthma | Phase 1 / Phase 2 | Completed | Advagene Biopharma Co. Ltd. | 40 | 2023-11-27 | 2025-09-10 |
Eosinophilia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypereosinophilic Syndrome (1) · Leukocyte Disorders (1) · Lung Diseases (1) · Respiratory Tract Diseases (1)
heat-labile enterotoxin, E coli (1)
Advagene Biopharma Co. Ltd. (1)
Taiwan (1)
Han-Pin Kuo, MD. Ph.D. (1) · Yushen Hsu, Ph.D. (1)